Biology Reference
In-Depth Information
Downs, W.G., Harper, P.A., Lisansky, E.T., 1947. Malaria and other insect-borne diseases in
the South Pacific campaign. II. Epidemiology of insect borne diseases in Army troops.
Am. J. Trop. Med. Hyg. 27, 69-89.
Druilhe, P., Brasseur, P., Blanc, C., Makler, M., 2007. Improved assessment of
Plasmodium vivax
response to antimalarial drugs by a colorimetric double-site plasmodium lactate dehy-
drogenase antigen capture enzyme-linked immunosorbent assay. Antimicrob. Agents
Chemother. 51, 2112-2116.
Ehrman, F.C., Ellis, J.M., Young, M.D., 1945.
Plasmodium vivax
Chesson Strain. Science
101, 377.
Elliott, J.H., O'Brien, D., Leder, K., Kitchener, S., Schwartz, E., et al., 2004. Imported
Plasmo-
dium vivax
malaria: demographic and clinical features in nonimmune travelers. J. Travel.
Med. 11, 213-217.
Elmes, N.J., Nasveld, P.E., Kitchener, S.J., Kocisko, D.A., Edstein, M.D., 2008. The efficacy
and tolerability of three different regimens of tafenoquine versus primaquine for post-
exposure prophylaxis of
Plasmodium vivax
malaria in the Southwest Pacific. Trans. R. Soc.
Trop. Med. Hyg. 102, 1095-1101.
Feachem, R.G., Phillips, A.A., Targett, G.A., Snow, R.W., 2010. Call to action: priorities for
malaria elimination. Lancet 376, 1517-1521.
Fernandez-Becerra, C., Pinazo, M.J., Gonzalez, A., Alonso, P.L., del Portillo, H.A., et al., 2009.
Increased expression levels of the pvcrt-o and pvmdr1 genes in a patient with severe
Plasmodium vivax
malaria. Malar. J. 8, 55.
Field, J.W., 1938. Notes on the Chemotherapy of Malaria. Bulletins from the Institute for
Medical Research Federated Malay States Printing, Kuala Lumpur 180 pp.
Freedman, D.O., Weld, L.H., Kozarsky, P.E., Fisk, T., Robins, R., et al., 2006. Spectrum of
disease and relation to place of exposure among ill returned travelers. N. Engl. J. Med.
354, 119-130.
Fryauff, D.J., Baird, J.K., Basri, H., Sumawinata, I., Purnomo, et al., 1995. Randomised pla-
cebo-controlled trial of primaquine for prophylaxis of falciparum and vivax malaria.
Lancet 346, 1190-1193.
Galappaththy, G.N., Omari, A.A., Tharyan, P., 2007. Primaquine for preventing relapses in
people with
Plasmodium vivax
malaria. Cochrane Database Syst. Rev., CD004389.
Gbotosho, G.O., Happi, C.T., Ganiyu, A., Ogundahunsi, O.A., Sowumni, A., et al., 2009.
Potential contribution of prescription practices to the emergence and spread of chloro-
quine resistance in south-west Nigeria: caution in the use of artemisinin combination
therapy. Malar. J. 8, 313.
Genton, B., D'Acremont, V., Rare, L., Bae, K., Reeder, J.C., et al., 2008.
Plasmodium vivax
and mixed infections are associated with severe malaria in children: a prospective cohort
study from Papua New Guinea. PLoS Med. 5, 6.
Gogtay, N.J., Desai, S., Kamtekar, K.D., Kadam, V.S., Dalvi, S.S., et al., 1999. Efficacies of
5- and 14-day primaquine regimens in the prevention of relapses in
Plasmodium vivax
infections. Ann. Trop. Med. Parasitol. 93, 809-812.
Goller, J.L., Jolley, D., Ringwald, P., Biggs, B.A., 2007. Regional differences in the response of
Plasmodium vivax
malaria to primaquine as anti-relapse therapy. Am. J. Trop. Med. Hyg.
76, 203-207.
Grassi, B., Feletti, R., 1890. Parasites malariques ches oiseaux. Arch Ital de Biologie
13, 297-300.
Greenwood, D., 1995. Conflicts of interest: the genesis of synthetic antimalarial agents in
peace and war. J. Antimicrob. Chemother. 36, 857-872.
Guthmann, J.P., Pittet, A., Lesage, A., Imwong, M., Lindegardh, N., et al., 2008.
Plasmodium vivax
resistance to chloroquine in Dawei, southern Myanmar. Trop. Med. Int. Health 13, 91-98.
Habib, A.G., Singh, K.S., 2004. Respiratory distress in nonimmune adults with imported
malaria. Infection 32, 356-359.
